Translocation t (5; 15)(p15; q11-q13) childhood acute lymphoblastic leukemia with heterogeneous prognosis implications
SH Lee, IS Kim, SE Jun, YT Lim… - Journal of Pediatric …, 2014 - journals.lww.com
1. Corona-Rivera A, Bobadilla-Morales L, Cruz-Osorio RM, et al. Translocation t (5; 15)(q15;
q11-13) infant case with acute lymphoblastic leukemia and literature review: prognosis …
q11-13) infant case with acute lymphoblastic leukemia and literature review: prognosis …
[PDF][PDF] Characteristics and outcomes of pediatric patients with t (16; 16)-acute myeloid leukemia, a study by the International Berlin-Frankfurt-Münster (BFM) Study …
K Klein, V de Haas, E Sonneveld, J Abrahamsson… - VU Research Portal - research.vu.nl
Studies evaluating clinical characteristics and potential risk factors associated with outcome
in pediatric patients with acute myeloid leukemia (AML) harboring t (16; 16)(p13. 1; …
in pediatric patients with acute myeloid leukemia (AML) harboring t (16; 16)(p13. 1; …
Acute Myeloid Leukemia with t (6; 9)(P23; Q34): Case Report
R Lasan Trčić, I Kardum-Skelin, Z Šiftar… - … European Congress of …, 2012 - croris.hr
Aim: The translocation (6; 9)(p23; q34) is a rare cytogenetic aberration found in patients with
acute myeloid leukemia (AML)(about 1% of all AML), and correlates with poor clinical …
acute myeloid leukemia (AML)(about 1% of all AML), and correlates with poor clinical …
[PDF][PDF] The t (1; 22)(p13; q13) is nonrandom and restricted to infants with acute
We report the nonrandom occurrence and frequency of the t (1; 22)(p13; q13) in acute
myeloid leukemia (AML) and its close association with the French-American-British M7 …
myeloid leukemia (AML) and its close association with the French-American-British M7 …
Translocation t (9; 11)(p21; q23) in pediatric de novo and secondary acute myeloblastic leukemia.
C Sandoval, DR Head, J Mirro Jr, FG Behm, GD Ayers… - Leukemia, 1992 - europepmc.org
The t (9; 11)(p21; q23) has been associated with characteristic clinical features and a
superior treatment outcome in previously untreated pediatric acute myeloblastic leukemia …
superior treatment outcome in previously untreated pediatric acute myeloblastic leukemia …
[引用][C] A new case of t (5; 15)(p15; q11∼ q13) in infant acute lymphoblastic leukemia
MLM Silva, GD de Brito, F Simões… - Cancer genetics …, 2001 - cancergeneticsjournal.org
Infant acute lymphoblastic leukemia (IALL), which occurs within the first 12 months of life,
clinically tends to have hepatosplenomegaly, leukocytosis, central nervous system …
clinically tends to have hepatosplenomegaly, leukocytosis, central nervous system …
Loss of i (8)(q10) at relapse in two cases of childhood acute myeloid leukaemia
L Seppa, H Hengartner, K Leibundgut… - Leukemia & …, 2007 - Taylor & Francis
Acute myeloid leukaemia (AML) is characterised by distinct nonrandom karyotypic changes
that in many cases have been recognised to represent one of the initial pathogenic changes …
that in many cases have been recognised to represent one of the initial pathogenic changes …
[HTML][HTML] Acute myeloid leukemia with t (4; 12)(q12; p13) treated with an allogeneic stem cell transplant: A case report and review of the literature
C Hancock, D Kanaloupitis, R Sirota… - Leukemia research …, 2018 - ncbi.nlm.nih.gov
The t (4; 12)(q12; p13) in acute myeloid leukemia (AML) is a rare finding with less than 30
cases described in the literature. The few cases reported show that this subtype of AML …
cases described in the literature. The few cases reported show that this subtype of AML …
[引用][C] Considerations on a case of acute leukemia with neurological manifestations & rare osseous localizations
G SPINELLI - Minerva Pediatrica, 1958 - europepmc.org
[Considerations on a case of acute leukemia with neurological manifestations & rare
osseous localizations]. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …
osseous localizations]. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …
[HTML][HTML] Detection of minimal residual disease in a patient having acute myelogenous leukemia with t (16; 21)(p11; q22) treated by allogeneic bone marrow …
Y Okoshi, S Shimizu, H Kojima, N Obara… - Acta …, 2001 - karger.com
A 29-year-old woman having acute myelogeneous leukemia-M1 subtype with the
chromosomal abnormality t (16; 21)(p11; q22) is presented. Complete blood count at onset …
chromosomal abnormality t (16; 21)(p11; q22) is presented. Complete blood count at onset …